Utilizing NMR to study the structure of growth-inhibitory proteins.
作者信息
Marassi Francesca
机构信息
The Burnham Institute, La Jolla, CA, USA.
出版信息
Methods Mol Biol. 2003;223:3-15. doi: 10.1385/1-59259-329-1:3.
Abstract
摘要
相似文献
1
Utilizing NMR to study the structure of growth-inhibitory proteins.
Methods Mol Biol. 2003;223:3-15. doi: 10.1385/1-59259-329-1:3.
2
Identification of Elongin C and Skp1 sequences that determine Cullin selection.
J Biol Chem. 2004 Oct 8;279(41):43019-26. doi: 10.1074/jbc.M408018200. Epub 2004 Jul 27.
3
Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C.
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9033-8. doi: 10.1073/pnas.96.16.9033.
4
Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide.
J Mol Biol. 2001 Sep 7;312(1):177-86. doi: 10.1006/jmbi.2001.4938.
5
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein.
J Clin Invest. 1999 Dec;104(11):1583-91. doi: 10.1172/JCI8161.
6
Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
J Biol Chem. 1997 Oct 24;272(43):27444-9. doi: 10.1074/jbc.272.43.27444.
7
Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
Eur J Endocrinol. 1996 Feb;134(2):157, 159. doi: 10.1530/eje.0.1340157.
8
The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein.
Biochim Biophys Acta. 1998 Apr 17;1377(2):M49-54. doi: 10.1016/s0304-419x(97)00035-8.
9
Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.
Science. 1995 Sep 8;269(5229):1444-6. doi: 10.1126/science.7660130.
10
Interaction of von Hippel-Lindau tumor suppressor gene product with elongin.
Methods Enzymol. 1996;274:436-41. doi: 10.1016/s0076-6879(96)74035-1.
引用本文的文献
1
The Role of CDKs and CDKIs in Murine Development.
Int J Mol Sci. 2020 Jul 28;21(15):5343. doi: 10.3390/ijms21155343.
本文引用的文献
1
Nuclear magnetic resonance of membrane-associated peptides and proteins.
Methods Enzymol. 2001;339:285-313. doi: 10.1016/s0076-6879(01)39319-9.
2
The solution structure of the disulphide-linked homodimer of the human trefoil protein TFF1.
FEBS Lett. 2001 Mar 30;493(2-3):70-4. doi: 10.1016/s0014-5793(01)02276-1.
3
Structure and functionality of a designed p53 dimer.
J Mol Biol. 2001 Mar 23;307(2):605-17. doi: 10.1006/jmbi.2001.4450.
4
Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53.
Biochemistry. 2001 Jan 16;40(2):336-44. doi: 10.1021/bi000930v.
5
Protein NMR spectroscopy in structural genomics.
Nat Struct Biol. 2000 Nov;7 Suppl:982-5. doi: 10.1038/80768.
6
Protein production: feeding the crystallographers and NMR spectroscopists.
Nat Struct Biol. 2000 Nov;7 Suppl:970-2. doi: 10.1038/80751.
7
Assignment of 1H(N), 15N, 13C(alpha), 13CO and 13C(beta) resonances in a 67 kDa p53 dimer using 4D-TROSY NMR spectroscopy.
J Biomol NMR. 2000 Oct;18(2):173-6. doi: 10.1023/a:1008317825976.
8
Lanthanide ions bind specifically to an added "EF-hand" and orient a membrane protein in micelles for solution NMR spectroscopy.
J Magn Reson. 2000 Oct;146(2):381-4. doi: 10.1006/jmre.2000.2172.
9
Tumor suppressor INK4: refinement of p16INK4A structure and determination of p15INK4B structure by comparative modeling and NMR data.
Protein Sci. 2000 Jun;9(6):1120-8. doi: 10.1110/ps.9.6.1120.
10
Structure of the negative regulatory domain of p53 bound to S100B(betabeta).
Nat Struct Biol. 2000 Jul;7(7):570-4. doi: 10.1038/76797.
Zotero 插件